Department of Health Law, Policy and Management, Boston University School of Public Health, Boston, MA, United States; Evans Center for Implementation and Improvement Sciences, Boston University School of Medicine, Boston, MA, United States.
Center for Health Equity Research, Brown University School of Public Health, Providence, RI, United States; Departments of Behavioral and Social Health Sciences and Epidemiology, Brown University School of Public Health, Providence, RI, United States; The Fenway Institute, Fenway Health, Boston, MA, United States.
Drug Alcohol Depend. 2019 May 1;198:80-86. doi: 10.1016/j.drugalcdep.2019.01.037. Epub 2019 Mar 8.
People who inject drugs (PWID) have limited engagement in healthcare services and report frequent experiences of stigma and mistreatment when accessing services. This paper explores the impact of stigma against injection drug use on healthcare utilization among PWID in the U.S. Northeast.
We recruited PWID through community-based organizations (CBOs; e.g., syringe service programs). Participants completed brief surveys and semi-structured interviews lasting approximately 45 min exploring HIV risk behaviors and prevention needs. Thematic analysis examined the emergent topic of stigma experiences in relation to healthcare utilization.
Among 33 PWID (55% male; age range 24-62 years; 67% White; 24% Latino), most used heroin (94%) and injected at least daily (60%). Experiences of dehumanization in healthcare settings were common, with many participants perceiving that they had been treated unfairly or discriminated against due to their injection drug use. As participants anticipated this type of stigma from healthcare providers, they developed strategies to avoid it, including delaying presenting for healthcare, not disclosing drug use, downplaying pain, and seeking care elsewhere. In contrast to large institutional healthcare settings, participants described non-stigmatizing environments within CBOs, where they experienced greater acceptance, mutual respect, and stronger connections with staff.
Stigma against injection drug use carries important implications for PWID health. Increased provider training on addiction as a medical disorder could improve PWID healthcare experiences, and integrating health services into organizations frequented by PWID could increase utilization of health services by this population.
注射毒品者(PWID)在医疗保健服务中的参与度有限,并且在获得服务时经常经历污名化和虐待。本文探讨了针对注射毒品的污名化对美国东北部 PWID 获得医疗保健服务的影响。
我们通过社区组织(例如,注射器服务计划)招募 PWID。参与者完成了简短的调查和持续约 45 分钟的半结构化访谈,探讨了 HIV 风险行为和预防需求。主题分析探讨了与医疗保健使用相关的污名化经验这一新兴主题。
在 33 名 PWID 中(55%为男性;年龄 24-62 岁;67%为白人;24%为拉丁裔),大多数人使用海洛因(94%),且至少每天注射一次(60%)。在医疗保健环境中,去人性化的经历很常见,许多参与者认为他们由于注射毒品而受到不公平对待或歧视。由于参与者预期到医疗服务提供者会产生这种类型的污名化,他们会制定策略来避免这种情况,包括延迟就医、不透露吸毒情况、轻描淡写疼痛和到其他地方寻求医疗服务。与大型机构医疗保健环境相比,参与者描述了 CBO 内没有污名化的环境,他们在这些环境中体验到了更多的接受、相互尊重和与工作人员更紧密的联系。
针对注射毒品的污名化对 PWID 的健康有重要影响。增加对成瘾作为一种医学疾病的提供者培训可能会改善 PWID 的医疗保健体验,并且将健康服务整合到 PWID 常去的组织中可能会增加该人群对健康服务的利用。